Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Pluri Inc.

PLUR · Nasdaq · CIK 0001158780 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

4 Form 4 transaction lines observed in the same window
0 sales · 4 option, withholding, award, gift or other lines

Last qualifying purchase2025-04-28 · Chutzpah Holdings Ltd; Manieu Alexandre Weinstein · $4.5M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Manieu Alexandre WeinsteinDirector,TenPercentOwner
○○
Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinDirector,TenPercentOwner; TenPercentOwner
○
SHORRER DORONDirector
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-04-28 · Chutzpah Holdings Ltd; Manieu Alexandre Weinstein.

Recent Form 4 activity

0Purchases
0Sales
14Other Form 4 lines
14SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER4 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
19,310
Previous report
19,902
Avg daily volume
20,756
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-04-28Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinPurchase (P)Common Stock452,702USD 4.61USD 2,086,956SEC filing ↗
2025-04-28Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinPurchase (P)Common Stock976,139USD 4.61USD 4,500,001SEC filing ↗
2022-02-10Aberman ZamiPurchase (P)Common Stock80,616USD 1.80USD 145,109SEC filing ↗
2020-11-30CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock20,000USD 9.70USD 194,000SEC filing ↗
2020-10-30CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock50,000USD 9.51USD 475,500SEC filing ↗
2020-10-29CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock20,000USD 9.20USD 184,000SEC filing ↗
2020-09-30CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock139,006USD 10.34USD 1,437,322SEC filing ↗
2020-09-29CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock60,123USD 9.76USD 586,800SEC filing ↗
2020-09-28CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock13,189USD 9.49USD 125,164SEC filing ↗
2020-09-24CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock34,800USD 9.02USD 313,896SEC filing ↗
2020-09-23CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock10,734USD 9.04USD 96,983SEC filing ↗
2020-07-31CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock14,536USD 9.43USD 137,074SEC filing ↗
2020-07-30CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock51,235USD 9.19USD 470,850SEC filing ↗
2020-07-29CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock121,926USD 9.03USD 1,100,992SEC filing ↗
2020-07-28CLOVER WOLF CAPITAL - LIMITED PARTNERSHIPPurchase (P)Common Stock81,198USD 8.46USD 686,935SEC filing ↗

Form 4 evidence

14 transaction lines in the latest 365-day window; 91 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-20SHORRER DORONAward / grant (A)Common Stock31,569USD 0.00USD 0SEC filing ↗
2026-08-20Manieu Alexandre WeinsteinAward / grant (A)Common Shares180,000USD 0.00USD 0SEC filing ↗
2026-06-30Manieu Alexandre WeinsteinAward / grant (A)Common Stock641USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (14 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-20SHORRER DORONAward / grant (A)Common Stock31,569USD 0.00USD 0SEC filing ↗
2026-08-20Manieu Alexandre WeinsteinAward / grant (A)Common Shares180,000USD 0.00USD 0SEC filing ↗
2026-06-30Manieu Alexandre WeinsteinAward / grant (A)Common Stock641USD 0.00USD 0SEC filing ↗
2026-04-21Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinAward / grant (A)Common Stock312,500USD 2.00USD 625,000SEC filing ↗
2025-12-08Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinAward / grant (A)Common Stock625,000USD 2.00USD 1,250,000SEC filing ↗
2025-12-04Zalts LiatAward / grant (A)Common Stock3,660USD 0.00USD 0SEC filing ↗
2025-12-04YANAY YAKYAward / grant (A)Common Stock6,588USD 0.00USD 0SEC filing ↗
2025-12-04Shemesh-Rasmussen MaitalAward / grant (A)Common Stock699USD 0.00USD 0SEC filing ↗
2025-12-04Levi Rami AvrahamAward / grant (A)Common Stock653USD 0.00USD 0SEC filing ↗
2025-12-04Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinAward / grant (A)Common Stock519USD 0.00USD 0SEC filing ↗
2025-12-04Ajchenbaum EitanAward / grant (A)Common Stock668USD 0.00USD 0SEC filing ↗
2025-12-04Aberman ZamiAward / grant (A)Common Stock346USD 0.00USD 0SEC filing ↗
2025-11-12Ajchenbaum EitanAward / grant (A)Common Stock11,685USD 0.00USD 0SEC filing ↗
2025-10-29Chutzpah Holdings Ltd; Manieu Alexandre WeinsteinOption exercise / conversion (M)Common Stock1,002,169USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPLUR
CIK0001158780
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history91 transaction lines from 2020-05-27 to 2026-08-20
34 P purchase lines · 12 S sale lines · 45 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.